Viridos Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
52
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$25M
- Investors
-
19
Viridos General Information
Description
Developer of a genomic-driven technology designed to address global energy and environmental challenges. The company's technology focuses on bio-based production targeted at improving existing biological production hosts and developing entirely new synthetic production hosts, enabling academic and commercial research and development organizations to efficiently produce pharmaceuticals, vaccines, and nutritional and bio-industrial products derived from renewable biological resources.
Contact Information
Website
www.viridos.comCorporate Office
- 11149 North Torrey Pines Road
- La Jolla, CA 92037
- United States
Corporate Office
- 11149 North Torrey Pines Road
- La Jolla, CA 92037
- United States
Viridos Timeline
Viridos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series A) | 13-Mar-2023 | $25M | Completed | Generating Revenue | ||
| 9. Grant | 26-Jan-2023 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series E1) | 22-Sep-2015 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series E) | 06-May-2014 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 05-Feb-2013 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2013 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2012 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 31-Dec-2010 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 31-May-2007 | $70M | $110M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 11-Oct-2005 | $40M | $40M | Completed | Startup |
Viridos Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E1 | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 13,793,094 | $0.002000 | 8% | $5.08 | $5.08 | $5.08 | 13.84% | |
| Series A | 7,696,653 | $0.002000 | 8% | $4 | $4 | 1x | $4 | 7.72% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Viridos Comparisons
Industry
Financing
Details
Viridos Competitors (1)
One of Viridos’s competitors is PhycoTerra, a Corporate Backed or Acquired company based in Gilbert, AZ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| PhycoTerra | Corporate Backed or Acquired | Gilbert, AZ |
Viridos Patents
Viridos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026024652-A1 | Recombinant algae having high biomass and lipid productivity | Pending | 22-Jul-2024 | ||
| WO-2025064430-A1 | Recombinant algae having high biomass and lipid productivity | Inactive | 18-Sep-2023 | ||
| WO-2025034558-A1 | Method for nuclear genome editing using plastid selectable markers | Inactive | 04-Aug-2023 | ||
| WO-2024097353-A1 | Recombinant algae having high biomass and lipid productivity | Inactive | 04-Nov-2022 | ||
| US-12618078-B2 | Chlorophyte algae having improved productivity | Active | 23-Apr-2021 | C12N9/22 |
Viridos Signals
Viridos Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Breakthrough Energy | Impact Investing | Minority | ||
| Chevron | Corporation | Minority | ||
| Draper Associates | Venture Capital | Minority | ||
| United Airlines Holdings | Holding Company | Minority | ||
| U.S. Department of Energy | Government |
Viridos Investments (2)
Viridos’s most recent deal was a Joint Venture with Algae Biofuel Research Program (ExxonMobil / Synthetic Genomics). The deal was made on 06-Mar-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Algae Biofuel Research Program (ExxonMobil / Synthetic Genomics) | 06-Mar-2018 | Joint Venture | Other Energy Services | ||
| Agradis | 24-Oct-2011 | Early Stage VC | Agricultural Chemicals |
Viridos FAQs
-
When was Viridos founded?
Viridos was founded in 2005.
-
Where is Viridos headquartered?
Viridos is headquartered in La Jolla, CA.
-
What is the size of Viridos?
Viridos has 52 total employees.
-
What industry is Viridos in?
Viridos’s primary industry is Other Agriculture.
-
Is Viridos a private or public company?
Viridos is a Private company.
-
What is Viridos’s current revenue?
The current revenue for Viridos is .
-
How much funding has Viridos raised over time?
Viridos has raised $330M.
-
Who are Viridos’s investors?
Breakthrough Energy, Chevron, Draper Associates, United Airlines Holdings, and U.S. Department of Energy are 5 of 19 investors who have invested in Viridos.
-
Who are Viridos’s competitors?
PhycoTerra is a competitor of Viridos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process